Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation

Anne Sig Vestergaard; Flemming Skjøth; Professor Gregory Lip; Torben Bjerregaard Larsen

doi:10.1161/strokeaha.115.012338

Abstract

1 min read

Resuming warfarin therapy within 90 days after ICH in patients with atrial fibrillation is associated with a decrease in average hospitalization costs.

Related publications

Article2017

Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation

Peter Brønnum Nielsen, Torben Bjerregaard Larsen, Flemming Skjøth, Professor Gregory Lip

Article2019

Oral Anticoagulation in Asian Patients With Atrial Fibrillation and a History of Intracranial Hemorrhage

So-Ryoung Lee, Eue-Keun Choi, Soonil Kwon, Jin‐Hyung Jung, Kyungdo Han, Myung‐Jin Cha, Seil Oh, Professor Gregory Lip

Article2025

Effect of oral anticoagulant therapy on adverse outcomes in patients with atrial fibrillation after intracranial hemorrhage

Wulamiding Kaisaier, Chaokun Guan, Min Ye, Siyu Guo, Yili Chen, Yugang Dong, Professor Gregory Lip, Chen Liu, Wengen Zhu

Article2013

Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation?

Maurizio Paciaroni, Giancarlo Agnelli

Article2020

Safety of Anticoagulation in Patients Treated With Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation

Michela Giustozzi, Monica Acciarresi, Giancarlo Agnelli, Valeria Caso, Fabio Bandini, Georgios Tsivgoulis, Shadi Yaghi, Karen L. Furie, Prasanna Tadi, Cecilia Becattini, Marialuisa Zedde, Azmil H. Abdul‐Rahim, Kennedy R. Lees, Andrea Alberti, Michele Venti, Cataldo D’Amore, Maria Giulia Mosconi, Ludovica Anna Cimini, Paolo Bovi, Monica Carletti, Alberto Rigatelli, Manuel Cappellari, ,